Archives
Caspase-3 Cleavage of NDUFS1 Drives Trichothecene-Induced Mi
2026-04-24
Caspase-3 Cleavage of NDUFS1 Drives Trichothecene-Induced Mitochondrial ROS
Study Background and Research Question
Trichothecenes, such as deoxynivalenol (DON) and T-2 toxin, are mycotoxins produced predominantly by Fusarium species and are recognized for their toxicity in humans and animals due to food contamination. Their adverse effects—ranging from immunosuppression to liver damage—are largely attributed to oxidative stress from excessive reactive oxygen species (ROS) production. While mitochondria and the endoplasmic reticulum (ER) are established sources of cellular ROS, the precise molecular events linking trichothecene exposure to ROS accumulation and mitochondrial dysfunction have remained incompletely understood (reference paper).Key Innovation from the Reference Study
The reference study provides a mechanistic breakthrough by demonstrating that caspase-3 activation is pivotal in trichothecene-induced ROS production and mitochondrial dysfunction. Specifically, the research identifies the mitochondrial electron transport chain (ETC) component NDUFS1 as a direct substrate for caspase-3. Upon trichothecene exposure, caspase-3 cleaves NDUFS1, leading to complex I disruption, electron leakage, and subsequent ROS amplification. Additionally, the study highlights the contributory role of ER oxidoreductase ERO1α in non-mitochondrial ROS generation, establishing a feedback loop between mitochondrial and ER oxidative stress (reference paper).Methods and Experimental Design Insights
The investigators employed a combination of in vivo (murine liver) and in vitro (hepatocyte culture) models to evaluate the molecular and functional consequences of DON and T-2 toxin exposure. Key approaches included:- Measurement of ROS levels using established fluorescence-based probes in live cells.
- Assessment of mitochondrial integrity and membrane potential (ΔΨm) following toxin treatment.
- Pharmacological inhibition and genetic knockdown of caspase-3 to determine causality.
- Site-directed mutagenesis of NDUFS1 (D255A) to abrogate the caspase-3 cleavage event.
- Analysis of ERO1α expression and activity to dissect ER contributions to overall ROS.
Protocol Parameters
- mitochondrial membrane potential assay | 10–200 nM (TMRE) | live-cell hepatocyte imaging | balances detection sensitivity and low cytotoxicity | workflow_recommendation
- ROS quantification (fluorescence-based) | as per manufacturer's dye protocol | hepatocyte and tissue studies | enables temporal tracking of ROS dynamics | workflow_recommendation
- caspase-3 inhibitor use | 10–50 μM (Z-DEVD-FMK) | in vitro apoptosis/ROS studies | blocks cleavage of NDUFS1 and reduces ROS | reference_paper
- NDUFS1 D255A mutant expression | as per standard transfection | mechanistic validation | demonstrates cleavage-dependency of ROS amplification | reference_paper
Core Findings and Why They Matter
The study establishes several key findings:- Trichothecene exposure rapidly activates caspase-3, resulting in the proteolytic cleavage of NDUFS1, a crucial subunit of mitochondrial complex I (reference paper).
- Cleavage of NDUFS1 disrupts electron transport, directly increasing mitochondrial ROS production and collapsing membrane potential (ΔΨm).
- Mutation of the caspase-3 cleavage site in NDUFS1 (D255A) significantly attenuates ROS accumulation, confirming the specificity of this pathway.
- Inhibition or knockdown of caspase-3 reduces both ROS levels and mitochondrial dysfunction, underscoring its central role in the toxicity mechanism.
- ERO1α, localized in the ER, independently contributes to ROS production, amplifying oxidative stress through cross-talk with mitochondrial pathways.
- Collectively, these events establish a feedback loop between mitochondrial and ER ROS generation, exacerbating hepatocellular injury.